Methylation of HpaII site at the human DXS16 locus on Xp22 as an assay forabnormal patterns of X inactivation

Citation
Mm. Khalifa et al., Methylation of HpaII site at the human DXS16 locus on Xp22 as an assay forabnormal patterns of X inactivation, AM J MED G, 98(1), 2001, pp. 64-69
Citations number
31
Categorie Soggetti
Molecular Biology & Genetics
Journal title
AMERICAN JOURNAL OF MEDICAL GENETICS
ISSN journal
01487299 → ACNP
Volume
98
Issue
1
Year of publication
2001
Pages
64 - 69
Database
ISI
SICI code
0148-7299(20010101)98:1<64:MOHSAT>2.0.ZU;2-4
Abstract
The highly polymorphic human DXS16 locus on Xp22 contains a BglII restricti on fragment length polymorphism with 33% heterozygosity. We report that met hylation of the HpaII site, 3.1 kb away from this restriction fragment leng th polymorphism, correlates with X-inactivation. The BglII polymorphism dis tinguishes between the maternal and paternal alleles, and HpaII digestion i dentifies their methylation status. The accuracy of this assay was tested o n more than 30 control females and some patients with known patterns of X-i nactivation. The data obtained from this assay agree substantially with tho se obtained using the androgen receptor assay, which is widely used for det ecting patterns of X-inactivation. This is the first marker on Xp22 found t o be suitable for clonal analysis. Of additional significance is this marke r's proximity to the pseudoautosomal boundary on the X chromosome and its p otential use in identifying rare events occurring in this region, which lea d to escape from normal X-inactivation, Am. J. Med. Genet. 98:64-69. (C) 20 01 Wiley-Liss, Inc.